Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025

RA'ANANA, Israel, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced that a national ministry of health in Africa   (the “Ministry of Health”) has placed a $27 million binding purchase order for Inspira’s FDA-cleared ART100 systems. The purchase order, secured through Inspira’s exclusive distribution partner, dedicated solely to the commercialization of Inspira’s products, initiates an immediate nationwide deployment program.